Clinical Trial Update: Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cotinine feedback to influence parental/caregiver smoking around children with cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: University of South Florida | Conditions: Pediatric Cancer | Phase 2 | Status: WITHDRAWN